TuzunEDalmauJ. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist2007; 13: 261–271.
2.
DalmauJGleichmanAJHughesE. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antobodies. Lancet Neurol2008; 7: 1091–1098.
3.
IraniSLangB. Autoantibody-mediated disorders of the central nervous system. Autoimmunity2008; 41: 55–65.
4.
SansingLHTuzunEKoMW. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol2007; 3: 291–296.
5.
FloranceNRDavisRLLamC. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adoloscents. Ann Neurol2009; 66: 11–18.
6.
KoideRShimizuTKoikeK. EFA6A-like antibodies in paraneoplastic encephalitis associated with immature ovarian teratoma: a case report. J Neurooncol2007; 81: 71–74.
7.
DaviesGIraniSRColtartC. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med2010; 38: 679–682.
8.
PrussHDalmauJHarmsL. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology2010; 75: 1735–1739.
9.
VarvatJLafondPPageY. Acute psychiatric syndrome leading young patients to ICU: consider anti-NMDA-receptor antibodies. Anaesth Intensive Care2010; 38: 748–750.
10.
DalmauJTuzunEWuHY. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol2007; 61: 25–36.
